FDA Rejects sNDA for Hetlioz in Jet Lag Disorder
The FDA has rejected the supplemental New Drug Application for Hetlioz (tasimelteon; Vanda Pharmaceuticals) for the treatment of jet lag disorder.
Sleep Disorders
Sleep Disorders Up Health Care Visits, Costs for Low Back Pain
However, sleep disorder does not lessen the impact of pain intensity, disability on health care utilization.
CPAP Alleviates Depression Symptoms in Sleep Apnea Patients
In large trial and literature review, benefit seen for depression but not anxiety symptoms.
Increased Obesity Risk in Women Exposed to Artificial Light at Night While Sleeping
Short sleep has been associated with obesity, but data on the association between exposure to artificial light at night while sleeping and risk for obesity have been inconclusive.
Irregular Sleep Patterns May Increase Risk for Metabolic Syndrome
Odds higher in 2 cross-sectional, prospective analyses after adjustment for sleep-related factors.
Single-Component Treatments Effective for Insomnia
Stimulus control and sleep restriction therapy more effective than multiple-component treatments.
Implementation of a Screening Questionnaire for Obstructive Sleep Apnea in the Electronic Medical Record
Patients with untreated obstructive sleep apnea have been shown to have numerous cognitive disturbances, which can lead to poor work performance, work errors, and poor quality of life.
FDA Puts Tough Warning Label on Ambien, Lunesta, Other Sleep Aids
Move spurred by 66 cases of ‘complex sleep behaviors’ after taking the insomnia medications.
Cognitive Behavioral Therapy Effective for Prenatal Insomnia
Women in CBT group had greater reductions in insomnia severity, were likely to have remission
Short Sleep Duration, Not OSA, Linked to Daytime Sleepiness
Short sleep duration is associated with daytime sleepiness, while obstructive sleep apnea is associated with obesity, hypertension, and dyslipidemia.
Next post in Sleep Information Center
